Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-02 5:36 pm Purchase | 2026-06-30 | 13D | LIFECORE BIOMEDICAL INC LFCR | Legion Partners Asset Management, LLC | 6,794,595 17.100% | 331,991 (+5.14%) | Filing History |
| 2026-07-02 5:15 pm Sale | 2026-06-30 | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund, LP | 2,712,472 6.740% | -262,926 (-8.84%) | Filing History |
| 2026-04-27 4:12 pm Sale | 2026-03-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | BlackRock Inc. BLK | 1,867,916 4.980% | -31,987 (-1.68%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | BlackRock Inc. BLK | 1,899,903 5.100% | 65,584 (+3.58%) | Filing History |
| 2025-10-17 6:41 pm Sale | 2025-09-30 | 13G | LIFECORE BIOMEDICAL INC LFCR | BlackRock Inc. BLK | 1,834,319 4.900% | -34,184 (-1.83%) | Filing History |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | LIFECORE BIOMEDICAL INC LFCR | BlackRock Inc. BLK | 1,868,503 5.000% | 1,336,460 (+251.19%) | Filing History |
| 2025-05-29 9:56 pm Sale | 2025-05-27 | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund, LP | 2,975,398 7.490% | -1,392,101 (-31.87%) | Filing History |
| 2025-02-14 4:44 pm Purchase | 2024-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | Greenhaven Road Investment Management L.P. | 3,616,146 9.800% | 1,249,190 (+52.78%) | Filing History |
| 2025-02-14 4:44 pm Purchase | 2023-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | Greenhaven Road Investment Management L.P. | 2,366,956 7.800% | 464,317 (+24.40%) | Filing History |
| 2025-02-05 3:24 pm Purchase | 2024-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | David Capital Partners, LLC | 1,803,000 4.870% | 148,000 (+8.94%) | Filing History |
| 2024-12-26 1:20 pm Purchase | 2024-12-23 | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund, LP | 4,367,499 11.100% | 264,278 (+6.44%) | Filing History |
| 2024-10-07 4:31 pm Purchase | 2024-10-03 | 13D | LIFECORE BIOMEDICAL INC LFCR | Legion Partners Asset Management, LLC | 6,462,604 16.600% | 1,500,790 (+30.25%) | Filing History |
| 2024-07-05 2:17 pm Unchanged | 2024-06-28 | 13D | LIFECORE BIOMEDICAL INC LFCR | Wynnefield Partners Small Cap Value, L.P. I | 5,007,666 16.000% | 0 (Unchanged) | Filing History |
| 2024-07-01 4:43 pm Unchanged | 2024-06-28 | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund, LP | 4,103,221 12.400% | 0 (Unchanged) | Filing History |
| 2024-07-01 4:05 pm Purchase | 2024-06-28 | 13D | LIFECORE BIOMEDICAL INC LFCR | Legion Partners Asset Management, LLC | 4,961,814 15.200% | 90,883 (+1.87%) | Filing History |
| 2024-06-11 5:27 pm Unchanged | 2024-06-11 | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund, LP | 4,103,221 12.500% | 0 (Unchanged) | Filing History |
| 2024-05-20 4:32 pm Purchase | 2024-05-16 | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund, LP | 4,103,221 12.500% | 43,216 (+1.06%) | Filing History |
| 2024-02-29 4:25 pm Unchanged | 2024-01-06 | 13D | LIFECORE BIOMEDICAL INC LFCR | 22NW Fund, LP | 4,060,005 12.440% | 0 (Unchanged) | Filing History |
| 2024-02-14 3:39 pm Purchase | 2023-12-31 | 13G | LIFECORE BIOMEDICAL INC LFCR | LW CAPITAL MANAGEMENT, LLC | 1,578,197 5.200% | 1,578,197 (New Position) | Filing History |
| 2024-02-09 09:59 am Sale | 2024-02-14 | 13G | LIFECORE BIOMEDICAL INC LFCR | DIMENSIONAL FUND ADVISORS LP | 1,940 0.000% | -1,755,604 (-99.89%) | Filing History |